Vista Pharmaceuticals Ltd — Quarterly Results & Earnings

₹6.11

+0.00%

Profit Growth YoY-167.01%Latest quarter

Sales Growth YoY-41.37%Latest quarter

Sales CAGR 5Y-15.53%5 year compound

Profit CAGR 5Y-5.94%5 year compound

📋

Quarterly Performance

YoY Profit Growth-167.01%

🔴 Significant decline

YoY Sales Growth-41.37%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

-64.82%

EPS Growth 5Y

-0.87%

Interest Coverage

Higher = safer debt servicing

-8.96

ROE

-10.83%

ROCE

-8.53%

💡

Growth Analysis

Vista Pharmaceuticals Ltd reported YoY profit growth of -167.01% and revenue growth of -41.37% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -15.53% and profits at -5.94% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Vista Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.